LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

Giulio Cavalli,Julia Weinmann-Menke, Clive Drakeford,Mi Kwon,Peter Gergely,Tamas Shisha,Pere Barba,Eva Wagner-Drouet, Josefina Cortés Hernández, José María Álvaro-Gracia Álvaro, Ozana Fischer, Beata Kovacs, Frédérique Chaperon,David Pearson, Tiina Kirsilä, Chih-Yung Sean Lee

Late-Breaking Abstracts（2024）

Cited 0|Views8

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined